StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Upgrade to SI Premium - Free Trial

Amarin Corp. (AMRN)

Amarin to Present at the 2023 Cantor Global Healthcare Conference September 12, 2023 8:00 AM - StreetInsider Form SC 13D/A AMARIN CORP PLC\UK Filed by: Sarissa Capital Management LP September 5, 2023 4:16 PM - SEC Filing Amarin's (AMRN) new CEO buys $300k in stock as promised August 17, 2023 10:07 AM - StreetInsider Form 4 AMARIN CORP PLC\UK For: Aug 16 Filed by: Holt Patrick August 16, 2023 7:52 PM - SEC Filing Form EFFECT AMARIN CORP PLC\UK August 16, 2023 6:02 AM - SEC Filing Amarin (AMRN) Provides Pricing & Reimbursement Updates for VAZKEPA in The Netherlands and Italy August 9, 2023 4:06 PM - StreetInsider Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands and Italy August 9, 2023 4:05 PM - Globe NewsWire Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands and Italy August 9, 2023 4:05 PM - StreetInsider BiomX Reports Second Quarter 2023 Financial Results and Provides Business Update August 9, 2023 6:30 AM - Globe NewsWire Amarin (AMRN) And Neopharm Enter Exclusive Commercialization Agreement for VAZKEPA in Israel August 8, 2023 7:02 AM - StreetInsider Amarin And Neopharm Announce Exclusive Commercialization Agreement for VAZKEPA® (Icosapent Ethyl) in Israel August 8, 2023 7:00 AM - Globe NewsWire Amarin Corp. (AMRN) VAZKEPA accepted by the Scottish Medicines Consortium August 7, 2023 7:01 AM - StreetInsider Scottish Medicines Consortium Accepts VAZKEPA® (icosapent ethyl) to Help Reduce Cardiovascular Risk for Patients in Scotland(1) August 7, 2023 7:00 AM - Globe NewsWire Form 4 AMARIN CORP PLC\UK For: Aug 01 Filed by: Holt Patrick August 2, 2023 5:07 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 31 Filed by: Berg Aaron August 2, 2023 5:01 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 31 Filed by: Ketchum Steven B August 2, 2023 5:01 PM - SEC Filing Form S-8 AMARIN CORP PLC\UK August 2, 2023 8:40 AM - SEC Filing Amarin Corp. (AMRN) Files $100M Mixed Shelf August 2, 2023 8:36 AM - StreetInsider Form S-3 AMARIN CORP PLC\UK August 2, 2023 8:35 AM - SEC Filing Amarin Corp. (AMRN) Tops Q2 EPS by 5c August 2, 2023 7:12 AM - StreetInsider Amarin Reports Second Quarter 2023 Financial Results August 2, 2023 7:11 AM - Globe NewsWire Form 10-Q AMARIN CORP PLC\UK For: Jun 30 August 2, 2023 7:07 AM - SEC Filing Form 8-K AMARIN CORP PLC\UK For: Aug 02 August 2, 2023 7:01 AM - SEC Filing Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea July 31, 2023 8:00 AM - StreetInsider Form 3 AMARIN CORP PLC\UK For: Jul 18 Filed by: Holt Patrick July 28, 2023 6:46 PM - SEC Filing Amarin Corp. (AMRN) Latest Research Evaluating Clinical Benefits of VASCEPA/VAZKEPA to be Presented at ESC Congress July 26, 2023 8:01 AM - StreetInsider Latest Research Evaluating Clinical Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the European Society of Cardiology (ESC) Congress July 26, 2023 8:00 AM - StreetInsider Amarin Corp. (AMRN) Receives Positive Recommendation from Spanish Drug Pricing Committee for National Reimbursement of VAZKEPA July 25, 2023 4:06 PM - StreetInsider Amarin Receives Positive Recommendation from Spanish Drug Pricing Committee for National Reimbursement of VAZKEPA® (icosapent ethyl) in Spain July 25, 2023 4:05 PM - StreetInsider Form 8-K AMARIN CORP PLC\UK For: Jul 21 July 25, 2023 6:02 AM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: Odysseas Kostas D July 21, 2023 9:18 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: DiPaolo Mark July 21, 2023 9:16 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: Sterling Louis III July 21, 2023 9:14 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: Cohen Paul July 21, 2023 9:14 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: O'Connor Oliver July 21, 2023 9:12 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: Horn Keith July 21, 2023 9:08 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: Bonfiglio Patrice Eadon July 21, 2023 9:06 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: Sullivan Diane E. July 21, 2023 9:05 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 19 Filed by: Berg Aaron July 21, 2023 5:04 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 19 Filed by: Reilly Thomas Charles July 21, 2023 5:02 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 19 Filed by: Ketchum Steven B July 21, 2023 5:02 PM - SEC Filing Form 8-K AMARIN CORP PLC\UK For: Jul 18 July 20, 2023 8:32 AM - SEC Filing Amarin Board of Directors Announces Executive Compensation Program for New President and CEO Patrick Holt July 20, 2023 8:00 AM - StreetInsider Amarin Corporation (AMRN) PT Lowered to $1.25 at Northland Capital Markets July 19, 2023 9:36 AM - StreetInsider Amarin (AMRN) PT Lowered to $1 at Goldman Sachs, "stock to remain range bound until execution improves" July 19, 2023 7:05 AM - StreetInsider Form 8-K AMARIN CORP PLC\UK For: Jul 18 July 18, 2023 4:26 PM - SEC Filing Amarin (AMRN) Appoints Patrick Holt as President and CEO July 18, 2023 4:16 PM - StreetInsider Amarin Corp. (AMRN) Announces Organizational Restructuring July 18, 2023 4:16 PM - StreetInsider Amarin Appoints Patrick Holt as President and Chief Executive Officer July 18, 2023 4:16 PM - StreetInsider Amarin Implements Organizational Restructuring to Strengthen the Company While Driving Patient Access to VASCEPA®/VAZKEPA® Globally July 18, 2023 4:15 PM - StreetInsider Form 4 AMARIN CORP PLC\UK For: Jun 20 Filed by: Reilly Thomas Charles July 5, 2023 4:47 PM - SEC Filing Full Article List